It's more than a result.
It's a person.

We're Driven To Know.
genetics-icon
Genetics

Innovative solutions that empower researchers, from ALS to fragile X syndrome.

Learn more about our Genetics portfolio
oncology-icon
Oncology

Solving complex molecular challenges, from leukemia to solid tumors.

Learn more about our Oncology portfolio
cdx-icon
Custom & Companion Diagnostics

One partner from clinical concept to product commercialization.

Learn more about partnering with us.
Spotlight

Asuragen Announces the Launch of AmplideX® PCR/CE SMN1/2 Kit

The AmplideX® PCR/CE SMN1 kit puts SMN1 and SMN2 copy number determination within reach of laboratories everywhere.

Learn more
Spotlight

Asuragen Expands Genetic Portfolio with Launch of AmplideX® PCR/CE HTT Kit

The AmplideX® PCR/CE HTT Kit is a simple, robust, and reliable test for the detection of CAG trinucleotide repeats within the HTT gene, aberrations which are associated with the development of Huntington’s Disease (HD).

Read more
Spotlight

Asuragen Expands Oncology Portfolio with CE Marking and Launch of QuantideX® NGS DNA Hotspot 21 Kit

Asuragen Expands Oncology Portfolio with CE Marking and Launch of QuantideX® NGS DNA Hotspot 21 Kit, a targeted, next-generation sequencing panel for the detection of clinically relevant variants across a multitude of tumor types, including non-small cell lung cancer, colorectal cancer, and melanoma.

Read More

The Latest from Asuragen

New Horizons for AmplideX® Technology: Portfolio Expansions to New High Complexity Targets & Beyond
Press Release
Asuragen Portfolio Expansion Continues with Launch of AmplideX® PCR/CE SMN1/2 Kit
Event
ESHG 2019: European Human Genetics Conference

Gothenburg, Sweden

Press Release
Asuragen Announces Launch of AmplideX® PCR/CE HTT Kit
Back To
Top

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close